BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related SCT
BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related SCT
About this item
Full title
Author / Creator
Piras, I S , Angius, A , Andreani, M , Testi, M , Lucarelli, G , Floris, M , Marktel, S , Ciceri, F , Nasa, G La , Fleischhauer, K , Roncarolo, M G , Bulfone, A , Gregori, S and Bacchetta, R
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
The genetic background of donor and recipient is an important factor determining the outcome of allogeneic hematopoietic SCT (allo-HSCT). We applied whole-genome analysis to investigate genetic variants—other than HLA class I and II—associated with negative outcome after HLA-identical sibling allo-HSCT in a cohort of 110 β-Thalassemic patients. We...
Alternative Titles
Full title
BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related SCT
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1664202891
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1664202891
Other Identifiers
ISSN
0268-3369
E-ISSN
1476-5365
DOI
10.1038/bmt.2014.177
